Timothy P. Clackson - 24 Jun 2021 Form 3 Insider Report for Elevation Oncology, Inc. (ELEV)

Role
Director
Signature
/s/ Shawn Leland, Attorney-in-Fact
Issuer symbol
ELEV
Transactions as of
24 Jun 2021
Net transactions value
$0
Form type
3
Filing time
24 Jun 2021, 18:14:01 UTC
Previous filing
21 Jun 2021
Next filing
06 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ELEV Common Stock 47,330 24 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock, of which 31,554 shares are unvested and subject to repurchase by the Issuer if the reporting person ceases to provide services to the Issuer prior to the vesting of the shares.